Reference health

Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis

https://doi.org/10.1136/annrheumdis-2020-218946
CiteStamped reference-health badge
22/22 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 22 checked references that resolve
resolves10.1016/S0140-6736(20)30746-7
First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment
resolves10.1053/j.gastro.2020.05.032
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
resolves10.1136/annrheumdis-2020-217871
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
resolves10.1097/BOR.0000000000000725
Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases
resolves10.1016/j.jclinepi.2009.06.005
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
resolves10.1186/2046-4053-2-111
PROSPERO’s progress and activities 2012/13
resolves10.1016/S2665-9913(20)30095-3
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries
resolves10.1136/annrheumdis-2020-217690
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
resolves10.1016/j.jclinepi.2010.07.017
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
resolves10.1056/NEJMc2009567
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
resolves10.1016/j.phrs.2020.105061
Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: Experience from humanitas center, Milan
resolves10.1001/jama.2020.5394
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
resolves10.1136/bmj.327.7414.557
Measuring inconsistency in meta-analyses
resolves10.2307/2533446
Operating Characteristics of a Rank Correlation Test for Publication Bias
resolves10.1136/bmj.315.7109.629
Bias in meta-analysis detected by a simple, graphical test
resolves10.1136/annrheumdis-2020-217763
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
resolves10.1053/j.gastro.2020.05.066
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease
resolves10.1186/s12931-020-01511-z
Inflammatory phenotyping predicts clinical outcome in COVID-19
resolves10.1016/j.cgh.2019.02.044
Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
resolves10.1080/14740338.2016.1240783
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis
resolves10.1148/radiol.2020200432
Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR
resolves10.1148/radiol.2020200642
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
The 6 references without a DOI — listed, not checked
no DOI — not checkedCOVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for rheumatology (CONTROL-19)
no DOI — not checked10.1136/annrheumdis-2020-218946_bib15
no DOI — not checkedSystematic review on IBD patients with COVID-19: it is time to take stock
no DOI — not checked10.1136/annrheumdis-2020-218946_bib21
no DOI — not checkedDexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report
no DOI — not checkedShould IBD patients be tested for active COVID-19 prior starting a biological treatment?
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1136/annrheumdis-2020-218946"><img src="https://citestamp.com/citestamped/10.1136/annrheumdis-2020-218946/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1136/annrheumdis-2020-218946/badge.svg)](https://citestamp.com/citestamped/10.1136/annrheumdis-2020-218946)